Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Low-molecular-weight heparin effective in cutaneous lichen planus

June 15, 1998

Access and Block Drug sign agreement for international rights to amlexanox

June 9, 1998

FDA approves ADCON-L

June 1, 1998

Pentoxifylline shows efficacy in treatment of pruritus in HIV-infected patients

June 1, 1998

Controlled trial of thalidomide for mucocutaneous lesions of Behcet's syndrome

May 28, 1998

FDA approves Apligraf Human Skin Equivalent for venous leg ulcers

May 27, 1998

Oral contraceptive approved for acne treatment in Canada

May 26, 1998

SKB patents another series of IL-8 antagonists

May 25, 1998

Solarase approved in Canada

May 25, 1998

TGF-beta3 proves ineffective for the treatment of oral mucositis

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.